Lorlatinib in patients with ALK-positive non-small-cell lung cancer: results from a global phase 2 study
Published Online: 2018-12-?
Journal: The Lancet Oncology•Publisher: Elsevier BV
Authors: Alessandra Bearz•Alice T Shaw•Antonello Abbattista•Benjamin Besse•Benjamin J Solomon•Chia-Chi Lin•D Ross Camidge•Eng Huat Tan•Enriqueta Felip•Gerson Peltz•Gregory J Riely•Holger Thurm•Jean-François Martini•Jill S Clancy•Joseph Chen•Leonard P James•Rita Chiari•Ross A Soo•Sai-Hong Ignatius Ou•Shirish M Gadgeel•Takashi Seto•Todd M Bauer
